BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16464770)

  • 1. The ethics and science of placebo-controlled trials: assay sensitivity and the Duhem-Quine thesis.
    Anderson JA
    J Med Philos; 2006 Feb; 31(1):65-81. PubMed ID: 16464770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
    Howick J
    Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical equipoise and the incoherence of research ethics.
    Miller FG; Brody H
    J Med Philos; 2007; 32(2):151-65. PubMed ID: 17454420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subject indifference and the justification of placebo-controlled trials.
    Veatch RM
    Am J Bioeth; 2002; 2(2):12-3. PubMed ID: 12189061
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploiting subjects in placebo-controlled trials.
    Jecker NS
    Am J Bioeth; 2002; 2(2):19-20. PubMed ID: 12189064
    [No Abstract]   [Full Text] [Related]  

  • 10. International collaborative trials, placebo controls and The Declaration of Helsinki: need for clarification in paragraph 32.
    Malik AY; Ghafoor F
    Indian J Med Ethics; 2012; 9(1):13-8. PubMed ID: 22319846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When argument fails.
    Weijer C
    Am J Bioeth; 2002; 2(2):10-1. PubMed ID: 12189060
    [No Abstract]   [Full Text] [Related]  

  • 12. Primum non nocere and randomised placebo-controlled surgical trials: a dilemma?
    Kishen TJ; Harris IA; Diwan AD
    ANZ J Surg; 2009 Jul; 79(7-8):508-9. PubMed ID: 19694653
    [No Abstract]   [Full Text] [Related]  

  • 13. The ethics of the placebo in clinical practice.
    Lichtenberg P; Heresco-Levy U; Nitzan U
    J Med Ethics; 2004 Dec; 30(6):551-4. PubMed ID: 15574442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trials in pediatric urology: a cautionary view from an ethical perspective.
    Braga LH; Bagli DJ; Lorenzo AJ
    J Pediatr Urol; 2010 Oct; 6(5):435-42. PubMed ID: 20347616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice.
    Lemmens T; Miller PB
    Am J Bioeth; 2002; 2(2):14-7. PubMed ID: 12189062
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic beneficence and placebo controls.
    Ackerman TF
    Am J Bioeth; 2002; 2(2):21-2. PubMed ID: 12189065
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical research should not be permitted to escape the ethical orbit of clinical care.
    Steinberg D
    Am J Bioeth; 2002; 2(2):27-8. PubMed ID: 12189069
    [No Abstract]   [Full Text] [Related]  

  • 18. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to conduct a placebo-controlled trial may be unethical.
    Cohen PJ
    Am J Bioeth; 2002; 2(2):24. PubMed ID: 12189067
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.